• Explore /
  • Poster
  • / Antiemetic efficacy of intravenous (IV) NEPA in patients with breast cancer (BC) receiving anthracycline/cyclophosphamide (AC) chemotherapy.

Antiemetic efficacy of intravenous (IV) NEPA in patients with breast cancer (BC) receiving anthracycline/cyclophosphamide (AC) chemotherapy.

Abstract Poster

Authors

Lee Schwartzberg

Lee S. Schwartzberg

West Cancer Center, Germantown, TN

Lee S. Schwartzberg, Matti S. Aapro

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2019 Supportive Care in Oncology Symposium

Session Type

Poster Session

Session Title

Poster Session B

Track

Mental Health and Psychological Well-being,Psychosocial and Spiritual/Cultural Assessment and Management,Models of Care,Patient Reported Outcomes and Patient Experience,Prevention, Assessment, and Management of Disease and Treatment-related Symptoms,Prognostication ,Survivorship and Late Effects of Cancer

Sub Track

Prevention, Assessment, and Management of Disease and Treatment-related Symptoms

Clinical Trial Registration Number

NCT03403712

Citation

J Clin Oncol 37, 2019 (suppl 31; abstr 115)

DOI

10.1200/JCO.2019.37.31_suppl.115

Abstract #

115

Poster Bd #

D4

Abstract Disclosures

Similar Posters

First Author: Lee S. Schwartzberg

First Author: Camilla Vieira de Reboucas

First Author: Rudolph M. Navari

First Author: Lee Steven Schwartzberg